調査レポート | • レポートコード：GIR-2104Z07456 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、がん免疫療法のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。がん免疫療法の種類別市場規模（モノクローナル抗体、免疫チェックポイント阻害薬、免疫系モジュレーター、がんワクチン、その他）、用途別市場規模（病院、外来手術センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・がん免疫療法の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Amgen、AstraZeneca、Bristol-Myers Squibb、Eli-Lilly、Roche、GlaxoSmithKline、Janssen Biotech、Merck、Novartis、Pfizer、Sanofi、Spectrum Pharmaceuticals、Takeda ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：モノクローナル抗体、免疫チェックポイント阻害薬、免疫系モジュレーター、がんワクチン、その他 ・用途別分析2016年-2026年：病院、外来手術センター、その他 ・がん免疫療法の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・がん免疫療法のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・がん免疫療法のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・がん免疫療法の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・がん免疫療法の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Immuno-oncology Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Immuno-oncology Therapy size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Immuno-oncology Therapy market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Immuno-oncology Therapy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Others
Market segment by Application, can be divided into
Hospitals
Ambulatory Surgical Center
Others
Market segment by players, this report covers
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli-Lilly
Roche
GlaxoSmithKline
Janssen Biotech
Merck
Novartis
Pfizer
Sanofi
Spectrum Pharmaceuticals
Takeda
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Immuno-oncology Therapy
1.2 Classification of Immuno-oncology Therapy by Type
1.2.1 Overview: Global Immuno-oncology Therapy Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Immuno-oncology Therapy Revenue Market Share by Type in 2020
1.2.3 Monoclonal Antibodies
1.2.4 Immune Checkpoint Inhibitors
1.2.5 Immune System Modulators
1.2.6 Cancer Vaccines
1.2.7 Others
1.3 Global Immuno-oncology Therapy Market by Application
1.3.1 Overview: Global Immuno-oncology Therapy Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Center
1.3.4 Others
1.4 Global Immuno-oncology Therapy Market Size & Forecast
1.5 Global Immuno-oncology Therapy Market Size and Forecast by Region
1.5.1 Global Immuno-oncology Therapy Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Immuno-oncology Therapy Market Size by Region, (2016-2021)
1.5.3 North America Immuno-oncology Therapy Market Size and Prospect (2016-2026)
1.5.4 Europe Immuno-oncology Therapy Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Immuno-oncology Therapy Market Size and Prospect (2016-2026)
1.5.6 South America Immuno-oncology Therapy Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Immuno-oncology Therapy Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Immuno-oncology Therapy Market Drivers
1.6.2 Immuno-oncology Therapy Market Restraints
1.6.3 Immuno-oncology Therapy Trends Analysis
2 Company Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen Immuno-oncology Therapy Product and Solutions
2.1.4 Amgen Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Amgen Recent Developments and Future Plans
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Immuno-oncology Therapy Product and Solutions
2.2.4 AstraZeneca Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 AstraZeneca Recent Developments and Future Plans
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business
2.3.3 Bristol-Myers Squibb Immuno-oncology Therapy Product and Solutions
2.3.4 Bristol-Myers Squibb Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.4 Eli-Lilly
2.4.1 Eli-Lilly Details
2.4.2 Eli-Lilly Major Business
2.4.3 Eli-Lilly Immuno-oncology Therapy Product and Solutions
2.4.4 Eli-Lilly Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Eli-Lilly Recent Developments and Future Plans
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Immuno-oncology Therapy Product and Solutions
2.5.4 Roche Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Roche Recent Developments and Future Plans
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline Immuno-oncology Therapy Product and Solutions
2.6.4 GlaxoSmithKline Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 GlaxoSmithKline Recent Developments and Future Plans
2.7 Janssen Biotech
2.7.1 Janssen Biotech Details
2.7.2 Janssen Biotech Major Business
2.7.3 Janssen Biotech Immuno-oncology Therapy Product and Solutions
2.7.4 Janssen Biotech Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Janssen Biotech Recent Developments and Future Plans
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business
2.8.3 Merck Immuno-oncology Therapy Product and Solutions
2.8.4 Merck Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Merck Recent Developments and Future Plans
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business
2.9.3 Novartis Immuno-oncology Therapy Product and Solutions
2.9.4 Novartis Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Novartis Recent Developments and Future Plans
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business
2.10.3 Pfizer Immuno-oncology Therapy Product and Solutions
2.10.4 Pfizer Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Pfizer Recent Developments and Future Plans
2.11 Sanofi
2.11.1 Sanofi Details
2.11.2 Sanofi Major Business
2.11.3 Sanofi Immuno-oncology Therapy Product and Solutions
2.11.4 Sanofi Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Sanofi Recent Developments and Future Plans
2.12 Spectrum Pharmaceuticals
2.12.1 Spectrum Pharmaceuticals Details
2.12.2 Spectrum Pharmaceuticals Major Business
2.12.3 Spectrum Pharmaceuticals Immuno-oncology Therapy Product and Solutions
2.12.4 Spectrum Pharmaceuticals Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Spectrum Pharmaceuticals Recent Developments and Future Plans
2.13 Takeda
2.13.1 Takeda Details
2.13.2 Takeda Major Business
2.13.3 Takeda Immuno-oncology Therapy Product and Solutions
2.13.4 Takeda Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Takeda Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Immuno-oncology Therapy Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Immuno-oncology Therapy Players Market Share
3.2.2 Top 10 Immuno-oncology Therapy Players Market Share
3.2.3 Market Competition Trend
3.3 Immuno-oncology Therapy Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Immuno-oncology Therapy Revenue and Market Share by Type (2016-2021)
4.2 Global Immuno-oncology Therapy Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Immuno-oncology Therapy Revenue Market Share by Application (2016-2021)
5.2 Immuno-oncology Therapy Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Immuno-oncology Therapy Revenue by Type (2016-2026)
6.2 North America Immuno-oncology Therapy Revenue by Application (2016-2026)
6.3 North America Immuno-oncology Therapy Market Size by Country
6.3.1 North America Immuno-oncology Therapy Revenue by Country (2016-2026)
6.3.2 United States Immuno-oncology Therapy Market Size and Forecast (2016-2026)
6.3.3 Canada Immuno-oncology Therapy Market Size and Forecast (2016-2026)
6.3.4 Mexico Immuno-oncology Therapy Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Immuno-oncology Therapy Revenue by Type (2016-2026)
7.2 Europe Immuno-oncology Therapy Revenue by Application (2016-2026)
7.3 Europe Immuno-oncology Therapy Market Size by Country
7.3.1 Europe Immuno-oncology Therapy Revenue by Country (2016-2026)
7.3.2 Germany Immuno-oncology Therapy Market Size and Forecast (2016-2026)
7.3.3 France Immuno-oncology Therapy Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Immuno-oncology Therapy Market Size and Forecast (2016-2026)
7.3.5 Russia Immuno-oncology Therapy Market Size and Forecast (2016-2026)
7.3.6 Italy Immuno-oncology Therapy Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Immuno-oncology Therapy Revenue by Type (2016-2026)
8.2 Asia-Pacific Immuno-oncology Therapy Revenue by Application (2016-2026)
8.3 Asia-Pacific Immuno-oncology Therapy Market Size by Region
8.3.1 Asia-Pacific Immuno-oncology Therapy Revenue by Region (2016-2026)
8.3.2 China Immuno-oncology Therapy Market Size and Forecast (2016-2026)
8.3.3 Japan Immuno-oncology Therapy Market Size and Forecast (2016-2026)
8.3.4 South Korea Immuno-oncology Therapy Market Size and Forecast (2016-2026)
8.3.5 India Immuno-oncology Therapy Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Immuno-oncology Therapy Market Size and Forecast (2016-2026)
8.3.7 Australia Immuno-oncology Therapy Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Immuno-oncology Therapy Revenue by Type (2016-2026)
9.2 South America Immuno-oncology Therapy Revenue by Application (2016-2026)
9.3 South America Immuno-oncology Therapy Market Size by Country
9.3.1 South America Immuno-oncology Therapy Revenue by Country (2016-2026)
9.3.2 Brazil Immuno-oncology Therapy Market Size and Forecast (2016-2026)
9.3.3 Argentina Immuno-oncology Therapy Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Immuno-oncology Therapy Revenue by Type (2016-2026)
10.2 Middle East & Africa Immuno-oncology Therapy Revenue by Application (2016-2026)
10.3 Middle East & Africa Immuno-oncology Therapy Market Size by Country
10.3.1 Middle East & Africa Immuno-oncology Therapy Revenue by Country (2016-2026)
10.3.2 Turkey Immuno-oncology Therapy Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Immuno-oncology Therapy Market Size and Forecast (2016-2026)
10.3.4 UAE Immuno-oncology Therapy Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Immuno-oncology Therapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Immuno-oncology Therapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Immuno-oncology Therapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Immuno-oncology Therapy Revenue (USD Million) by Region (2016-2021)
Table 5. Global Immuno-oncology Therapy Revenue Market Share by Region (2021-2026)
Table 6. Amgen Corporate Information, Head Office, and Major Competitors
Table 7. Amgen Major Business
Table 8. Amgen Immuno-oncology Therapy Product and Solutions
Table 9. Amgen Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 11. AstraZeneca Major Business
Table 12. AstraZeneca Immuno-oncology Therapy Product and Solutions
Table 13. AstraZeneca Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 15. Bristol-Myers Squibb Major Business
Table 16. Bristol-Myers Squibb Immuno-oncology Therapy Product and Solutions
Table 17. Bristol-Myers Squibb Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Eli-Lilly Corporate Information, Head Office, and Major Competitors
Table 19. Eli-Lilly Major Business
Table 20. Eli-Lilly Immuno-oncology Therapy Product and Solutions
Table 21. Eli-Lilly Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Roche Corporate Information, Head Office, and Major Competitors
Table 23. Roche Major Business
Table 24. Roche Immuno-oncology Therapy Product and Solutions
Table 25. Roche Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 27. GlaxoSmithKline Major Business
Table 28. GlaxoSmithKline Immuno-oncology Therapy Product and Solutions
Table 29. GlaxoSmithKline Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Janssen Biotech Corporate Information, Head Office, and Major Competitors
Table 31. Janssen Biotech Major Business
Table 32. Janssen Biotech Immuno-oncology Therapy Product and Solutions
Table 33. Janssen Biotech Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Merck Corporate Information, Head Office, and Major Competitors
Table 35. Merck Major Business
Table 36. Merck Immuno-oncology Therapy Product and Solutions
Table 37. Merck Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Novartis Corporate Information, Head Office, and Major Competitors
Table 39. Novartis Major Business
Table 40. Novartis Immuno-oncology Therapy Product and Solutions
Table 41. Novartis Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Pfizer Corporate Information, Head Office, and Major Competitors
Table 43. Pfizer Major Business
Table 44. Pfizer Immuno-oncology Therapy Product and Solutions
Table 45. Pfizer Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Sanofi Corporate Information, Head Office, and Major Competitors
Table 47. Sanofi Major Business
Table 48. Sanofi Immuno-oncology Therapy Product and Solutions
Table 49. Sanofi Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Spectrum Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 51. Spectrum Pharmaceuticals Major Business
Table 52. Spectrum Pharmaceuticals Immuno-oncology Therapy Product and Solutions
Table 53. Spectrum Pharmaceuticals Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Takeda Corporate Information, Head Office, and Major Competitors
Table 55. Takeda Major Business
Table 56. Takeda Immuno-oncology Therapy Product and Solutions
Table 57. Takeda Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Global Immuno-oncology Therapy Revenue (USD Million) by Players (2019-2021)
Table 59. Global Immuno-oncology Therapy Revenue Share by Players (2019-2021)
Table 60. Breakdown of Immuno-oncology Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Immuno-oncology Therapy Players Head Office, Products and Services Provided
Table 62. Immuno-oncology Therapy Mergers & Acquisitions in the Past Five Years
Table 63. Immuno-oncology Therapy New Entrants and Expansion Plans
Table 64. Global Immuno-oncology Therapy Revenue (USD Million) by Type (2016-2021)
Table 65. Global Immuno-oncology Therapy Revenue Share by Type (2016-2021)
Table 66. Global Immuno-oncology Therapy Revenue Forecast by Type (2021-2026)
Table 67. Global Immuno-oncology Therapy Revenue by Application (2016-2021)
Table 68. Global Immuno-oncology Therapy Revenue Forecast by Application (2021-2026)
Table 69. North America Immuno-oncology Therapy Revenue by Type (2016-2021) & (USD Million)
Table 70. North America Immuno-oncology Therapy Revenue by Type (2021-2026) & (USD Million)
Table 71. North America Immuno-oncology Therapy Revenue by Application (2016-2021) & (USD Million)
Table 72. North America Immuno-oncology Therapy Revenue by Application (2021-2026) & (USD Million)
Table 73. North America Immuno-oncology Therapy Revenue by Country (2016-2021) & (USD Million)
Table 74. North America Immuno-oncology Therapy Revenue by Country (2021-2026) & (USD Million)
Table 75. Europe Immuno-oncology Therapy Revenue by Type (2016-2021) & (USD Million)
Table 76. Europe Immuno-oncology Therapy Revenue by Type (2021-2026) & (USD Million)
Table 77. Europe Immuno-oncology Therapy Revenue by Application (2016-2021) & (USD Million)
Table 78. Europe Immuno-oncology Therapy Revenue by Application (2021-2026) & (USD Million)
Table 79. Europe Immuno-oncology Therapy Revenue by Country (2016-2021) & (USD Million)
Table 80. Europe Immuno-oncology Therapy Revenue by Country (2021-2026) & (USD Million)
Table 81. Asia-Pacific Immuno-oncology Therapy Revenue by Type (2016-2021) & (USD Million)
Table 82. Asia-Pacific Immuno-oncology Therapy Revenue by Type (2021-2026) & (USD Million)
Table 83. Asia-Pacific Immuno-oncology Therapy Revenue by Application (2016-2021) & (USD Million)
Table 84. Asia-Pacific Immuno-oncology Therapy Revenue by Application (2021-2026) & (USD Million)
Table 85. Asia-Pacific Immuno-oncology Therapy Revenue by Region (2016-2021) & (USD Million)
Table 86. Asia-Pacific Immuno-oncology Therapy Revenue by Region (2021-2026) & (USD Million)
Table 87. South America Immuno-oncology Therapy Revenue by Type (2016-2021) & (USD Million)
Table 88. South America Immuno-oncology Therapy Revenue by Type (2021-2026) & (USD Million)
Table 89. South America Immuno-oncology Therapy Revenue by Application (2016-2021) & (USD Million)
Table 90. South America Immuno-oncology Therapy Revenue by Application (2021-2026) & (USD Million)
Table 91. South America Immuno-oncology Therapy Revenue by Country (2016-2021) & (USD Million)
Table 92. South America Immuno-oncology Therapy Revenue by Country (2021-2026) & (USD Million)
Table 93. Middle East & Africa Immuno-oncology Therapy Revenue by Type (2016-2021) & (USD Million)
Table 94. Middle East & Africa Immuno-oncology Therapy Revenue by Type (2021-2026) & (USD Million)
Table 95. Middle East & Africa Immuno-oncology Therapy Revenue by Application (2016-2021) & (USD Million)
Table 96. Middle East & Africa Immuno-oncology Therapy Revenue by Application (2021-2026) & (USD Million)
Table 97. Middle East & Africa Immuno-oncology Therapy Revenue by Country (2016-2021) & (USD Million)
Table 98. Middle East & Africa Immuno-oncology Therapy Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Immuno-oncology Therapy Picture
Figure 2. Global Immuno-oncology Therapy Revenue Market Share by Type in 2020
Figure 3. Monoclonal Antibodies
Figure 4. Immune Checkpoint Inhibitors
Figure 5. Immune System Modulators
Figure 6. Cancer Vaccines
Figure 7. Others
Figure 8. Immuno-oncology Therapy Revenue Market Share by Application in 2020
Figure 9. Hospitals Picture
Figure 10. Ambulatory Surgical Center Picture
Figure 11. Others Picture
Figure 12. Global Immuno-oncology Therapy Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Immuno-oncology Therapy Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Immuno-oncology Therapy Revenue Market Share by Region (2016-2026)
Figure 15. Global Immuno-oncology Therapy Revenue Market Share by Region in 2020
Figure 16. North America Immuno-oncology Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Immuno-oncology Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Immuno-oncology Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Immuno-oncology Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Immuno-oncology Therapy Market Drivers
Figure 21. Immuno-oncology Therapy Market Restraints
Figure 22. Immuno-oncology Therapy Market Trends
Figure 23. Amgen Recent Developments and Future Plans
Figure 24. AstraZeneca Recent Developments and Future Plans
Figure 25. Bristol-Myers Squibb Recent Developments and Future Plans
Figure 26. Eli-Lilly Recent Developments and Future Plans
Figure 27. Roche Recent Developments and Future Plans
Figure 28. GlaxoSmithKline Recent Developments and Future Plans
Figure 29. Janssen Biotech Recent Developments and Future Plans
Figure 30. Merck Recent Developments and Future Plans
Figure 31. Novartis Recent Developments and Future Plans
Figure 32. Pfizer Recent Developments and Future Plans
Figure 33. Sanofi Recent Developments and Future Plans
Figure 34. Spectrum Pharmaceuticals Recent Developments and Future Plans
Figure 35. Takeda Recent Developments and Future Plans
Figure 37. Global Immuno-oncology Therapy Revenue Share by Players in 2020
Figure 38. Immuno-oncology Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 39. Global Top 3 Players Immuno-oncology Therapy Revenue Market Share in 2020
Figure 40. Global Top 10 Players Immuno-oncology Therapy Revenue Market Share in 2020
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 42. Global Immuno-oncology Therapy Revenue Share by Type in 2020
Figure 43. Global Immuno-oncology Therapy Market Share Forecast by Type (2021-2026)
Figure 44. Global Immuno-oncology Therapy Revenue Share by Application in 2020
Figure 45. Global Immuno-oncology Therapy Market Share Forecast by Application (2021-2026)
Figure 46. North America Immuno-oncology Therapy Sales Market Share by Type (2016-2026)
Figure 47. North America Immuno-oncology Therapy Sales Market Share by Application (2016-2026)
Figure 48. North America Immuno-oncology Therapy Revenue Market Share by Country (2016-2026)
Figure 49. United States Immuno-oncology Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Canada Immuno-oncology Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Mexico Immuno-oncology Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Europe Immuno-oncology Therapy Sales Market Share by Type (2016-2026)
Figure 53. Europe Immuno-oncology Therapy Sales Market Share by Application (2016-2026)
Figure 54. Europe Immuno-oncology Therapy Revenue Market Share by Country (2016-2026)
Figure 55. Germany Immuno-oncology Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. France Immuno-oncology Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. United Kingdom Immuno-oncology Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Russia Immuno-oncology Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Italy Immuno-oncology Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Asia-Pacific Immuno-oncology Therapy Sales Market Share by Type (2016-2026)
Figure 61. Asia-Pacific Immuno-oncology Therapy Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Immuno-oncology Therapy Revenue Market Share by Region (2016-2026)
Figure 63. China Immuno-oncology Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Japan Immuno-oncology Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South Korea Immuno-oncology Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. India Immuno-oncology Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Southeast Asia Immuno-oncology Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Australia Immuno-oncology Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South America Immuno-oncology Therapy Sales Market Share by Type (2016-2026)
Figure 70. South America Immuno-oncology Therapy Sales Market Share by Application (2016-2026)
Figure 71. South America Immuno-oncology Therapy Revenue Market Share by Country (2016-2026)
Figure 72. Brazil Immuno-oncology Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Argentina Immuno-oncology Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Middle East and Africa Immuno-oncology Therapy Sales Market Share by Type (2016-2026)
Figure 75. Middle East and Africa Immuno-oncology Therapy Sales Market Share by Application (2016-2026)
Figure 76. Middle East and Africa Immuno-oncology Therapy Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Immuno-oncology Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Immuno-oncology Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. UAE Immuno-oncology Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source
世界の免疫腫瘍療法市場規模・現状・予測（2021年-2027年） Cancer immunotherapy (sometimes called immuno-oncology) is the use of the immune system to treat cancer. Market Analysis and Insights: Global Immuno-oncology Therapy Market The global Immuno-oncology Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a …- 世界の免疫腫瘍治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Immuno-Oncology Treatment Market The global Immuno-Oncology Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, th…
- 世界の免疫腫瘍薬市場 2021：企業別、地域別、種類・用途別 The Immuno-oncology Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
- 世界の膵臓がん治療市場規模・現状・予測（2021年-2027年） Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity …
- 世界の整形外科腫瘍学市場規模・現状・予測（2021年-2027年） Orthopaedic oncology is a new sub-speciality of orthopaedics which deals with the detection, treatment and follow-up of bone and soft tissue tumours. Market Analysis and Insights: Global Orthopaedic Oncology Market The global Orthopaedic Oncology market size is projected to reach US$ XX million by 2…